$64.68
0.08 (+0.12%)
Johnson & Johnson (NYSE:JNJ)
CAPS Rating:
A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.
RSS Headlines
Fool UK
Recs
I don't like investing in individual pharma companies as a rule: too much risk in any individual company. J&J is the exception; it's a bit like owning a pharma ETF. Plus it's one of the world's better run companies. You won't hit a home run, but with reinvested dividends, you'll earn a respectable return over time. Sleep at night with J&J.